C07C 215/10
With one amino group and at least two hydroxy groups bound to
Official title: with one amino group and at least two hydroxy groups bound to the carbon skeleton
C07C215/10 (With one amino group and at least two hydroxy groups bound to) appears on 170 US grants and 185 published applications in this corpus.
Search patents in C07C- Granted patents
- 170
- Published applications
- 185
- Assignees
- 166
- Inventors
- 572
- Latest grant
- 19 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 7 | 0 |
| 1989 | 5 | 0 |
| 1990 | 2 | 0 |
| 1991 | 3 | 0 |
| 1992 | 2 | 0 |
| 1993 | 4 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 5 | 0 |
| 1997 | 4 | 0 |
| 1998 | 9 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 2 |
| 2003 | 3 | 5 |
| 2004 | 5 | 3 |
| 2005 | 1 | 2 |
| 2006 | 5 | 2 |
| 2007 | 0 | 3 |
| 2008 | 1 | 2 |
| 2009 | 3 | 2 |
| 2010 | 2 | 3 |
| 2011 | 1 | 6 |
| 2012 | 3 | 9 |
| 2013 | 8 | 8 |
| 2014 | 5 | 12 |
| 2015 | 10 | 16 |
| 2016 | 9 | 10 |
| 2017 | 6 | 9 |
| 2018 | 6 | 13 |
| 2019 | 11 | 13 |
| 2020 | 8 | 11 |
| 2021 | 12 | 14 |
| 2022 | 6 | 5 |
| 2023 | 1 | 10 |
| 2024 | 3 | 6 |
| 2025 | 7 | 11 |
| 2026 | 3 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Artificially synthesized sphingosine derivative lipoid monomer and use of same for delivering nucleic acid19 May 2026US 12,629,421 B2Beijing Baishihekang Pharmaceutical Technology (Bsjpharma) Co., Ltd
- Stereoselective process for preparing substituted polycyclic pyridone28 Apr 2026US 12,612,415 B2Shionogi & Co., Ltd.
- Crystalline or amorphous form of Bcl-2/Bcl-xL inhibitor compound or its salts20 Jan 2026US 12,528,832 B2Ascentage Pharma Group Corp Limited
- Salts of R-ketorolac9 Dec 2025US 12,492,206 B2UNM Rainforest Innovations
- 3-(5-chloro-2-oxobenzo[d]oxazol-3(2H)-yl) propanoic acid derivatives as KMO inhibitors4 Nov 2025US 12,459,906 B2Dr. Falk Pharma GmbH
- Crystalline forms or salts of a deuterated compound13 Aug 2026US 2026/0234135 A1Alebund Pharmaceuticals (Hong Kong) Limited
- Artificially synthesized sphingosine derivative lipoid monomer and use of same for delivering nucleic acid6 Aug 2026US 2026/0224704 A1Beijing Baishihekang Pharmaceutical Technology (Bsjpharma) Co., Ltd
- Salt and crystal form of cycloalkene compound, and preparation method therefor and use thereof6 Aug 2026US 2026/0226046 A1Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- Solid forms of 1-(4-(4-((3-(3,6-difluoropyridin-2-yl)-1-((1r,4r)-4-ethoxycyclohexyl)-1h-pyrazol-4-yl)carbamoyl)thiazol-2-yl)-1h-pyrazol-1-yl)ethyl phosphate and salts thereof, and their pharmaceutical compositions and uses11 Jun 2026US 2026/0159538 A1Rigel Pharmaceuticals, Inc.
- Polymorph of glp-1r agonist compound, preparation method therefor, and use thereof12 Mar 2026US 2026/0069582 A1Mindrank Ai Ltd.
Most cited
By later US patents
- Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method143US 7,427,678 B2Sigma-Aldrich Co. · 2008
- Derivatives of 4-hydroxybutyric acid103US 5,753,708 A1998
- Derivatives of 4-hydroxybutyric acid84US 5,380,937 A1995
- 2-amino-1,3-propanediol compound and immunosuppressant76US 5,604,229 ATaito Co., Ltd. · 1997
- Contrast agents and compositions for radiological imaging, and radiological imaging method utilizing same59US 5,545,397 ABoron Biologicals, Inc. · 1996